glp-1 reviews and complaints Current Insights, Advantages Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review A new review by Clifford
Description
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects
Some people report subtle shifts in energy or appetite patterns, while others notice nothing yet
Fatigue emerged as the second most frequently reported complaint despite limited representation in RCT datasets which may reflect differences between structured trial environments and real-world use
2021;12:1321 10.3390/mi12111321
[DOI] [PubMed] [Google Scholar] 49.GLP-1 receptor agonist effects on normal and neoplastic pancreata
